Skip to main content
ConductScienceScienceDex
NIH funding notice RFA-CA-14-502

Limited Competition: AIDS Malignancy Clinical Trials Consortium (UM1)

Closed on January 6, 2015.

Posted
August 8, 2014
Close date
January 6, 2015
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 renewal
First-year cost
$13,134,495
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. UNIVERSITY OF CALIFORNIA LOS ANGELES1

Most frequent study sections

  1. Special Emphasis Panel (ZCA1 PCRB-G (A1))1
1 award under RFA-CA-14-502 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2015AIDS Malignancy Consortium (AMC)2UM1CA121947-09Mitsuyasu, Ronald T.UNIVERSITY OF CALIFORNIA LOS ANGELES, CAFirst-year cost $13,134,495Study section ZCA1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-16-0.3.5. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.

RFA-CA-14-502: Limited Competition: AIDS Malignancy Clinical Trials Consortium (UM1) | ConductScience ScienceDex